Total Funding
$410M
Employee Range
101-250
Century Therapeutics builds an allogeneic iPSC-derived cell therapy platform that integrates gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical needs.
Century Therapeutics data powered by:
Share
Century Therapeutics data powered by:
Century TherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Century TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
1st
In Philadelphia
Top 1%out of 104 startups
National Rank
Share
349th
In United States
Top 4%out of 8869 startups
Regional Rank
Share
366th
In North America
Top 4%out of 9671 startups
Century TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Philadelphia
Top 2%out of 51 startups
National Rank
Share
84th
In United States
Top 3%out of 3470 startups
Regional Rank
Share
89th
In North America
Top 3%out of 3721 startups
rankings by:
Century TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Century TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro